Octarine Bio raised €5.0M in a funding round in Jan 2026. The company is based in Copenhagen, Denmark. Investors in the round: dsm-firmenich Ventures, Edaphon, Oskare Capital and 4 others. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €5.0M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
